Newborns at risk for congenital toxoplasmosis, review of 16 years
DOI:
https://doi.org/10.15448/1980-6108.2018.4.32169Keywords:
infectious disease transmission, vertical, toxoplasmosis, congenital, chorioretinitis, cross-sectional studies, prevalence.Abstract
AIMS: To analyze the data on pregnancies with risk of congenital toxoplasmosis and to investigate the newborns' outcome, in a level II hospital in Portugal.
METHODS: A cross-sectional retrospective study included newborns at risk for congenital toxoplasmosis and their mothers, whose delivery occurred between January 2000 and December 2015. The inclusion criteria were mother with seroconversion to toxoplasmosis during pregnancy or first serum sample with positive specific IgM and IgG. The diagnosis of congenital toxoplasmosis was defined by positive specific IgM at birth and/or polymerase chain reaction positive in amniotic fluid and/or persistence of specific IgG up to 12 months of life. Congenital toxoplasmosis was defined as symptomatic when clinical findings were attributed to the disease. Chi-square or Fisher's exact tests were used to test associations between variables, assuming statistical significance when p <0.05.
RESULTS: There were 39,585 live births in the study period and 98 cases with risk of congenital toxoplasmosis were identified, of which 89 completed the follow-up. The prevalence of anti-T. gondii IgG in the pregnant women was 26% (95% confidence interval [CI] 24-27%). Twenty-two cases of congenital toxoplasmosis (5.6 per 10,000 live births, 95%CI 3.5-8.5 per 10,000) were confirmed. Of the 22 newborns, 18 (82%, 95%CI 61-93%) were symptomatic. The most frequent clinical findings were intracranial calcification (64%), hepatomegaly and / or elevation of transaminases (32%) and retinochoroiditis (14%). Cerebral lesions were more frequent when maternal infection was documented in the first and second trimester compared to the third trimester (p=0.018). In 31 cases (35%), the pregnant women were treated from the time of diagnosis until delivery with spiramycin, and no differences were found regarding the rate of vertical transmission or the appearance of clinical manifestations among the newborns of treated and non-treated mothers treated.
CONCLUSIONS: The prevalence of congenital toxoplasmosis was higher than that reported in other European countries. The prevalence of intracranial calcifications was higher than that described in the literature, whereas retinochoroiditis and strabismus occurrence was lower. Brain lesions in newborns were more frequent in first- and second-trimester infections. There was no difference in the rate of vertical transmission and in the occurrence of clinical manifestations among newborns whose mothers received spiramycin during gestation and those whose mothers did not receive treatment.
Downloads
References
Bischoff AR, Friedrich L, Cattan JM, Uberti FAF. Incidence of Symptomatic Congenital Toxoplasmosis During Ten Years in a Brazilian Hospital. Pediatr Infect Dis J. 2016;35(12):1313-6. https://doi.org/10.1097/INF.0000000000001307
Remigton JS, McLeod R, Tulliez P. Toxoplasmosis. In: Remington JS, Klein JO, Wilson CB, Baker CJ., eds. Infectious Diseases of the Fetus and Newborn Infant, Volume 31, 6th edition. United States of America: Saunders Elsevier; 2006:947-1091. https://doi.org/10.1016/B0-72-160537-0/50033-5
McAuley JB, Boyer K, Remington JS, McLeod R. Toxoplasmosis. In: Feigin RD, Cherry J, Demmler-Harrison GJ, Kaplan SL., eds. Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 6th edition. United States of America: Elsevier; 2009:2954-71.
Moncada PA, Montoya JG. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Rev Anti Infect Ther. 2012;10:815-28. https://doi.org/10.1586/eri.12.58
Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008;47:554-66. https://doi.org/10.1086/590149
Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, Abroms I, Pasternack MS, Hoff R, Eaton RB, Grady GF. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med. 1994;330(26):1858-63. https://doi.org/10.1056/NEJM199406303302604
Thiébaut R, Leproust S, Chêne G, Gilbert R, SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet. 2007;369:115-22. https://doi.org/10.1016/S0140-6736(07)60072-5
Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 1999;353:1829-33. https://doi.org/10.1016/S0140-6736(98)08220-8
Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965-76. https://doi.org/10.1016/S0140-6736(04)16412-X
Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, Wallon M, King L, Goulet V, Toxosurv network and National Reference Centre for Toxoplasmosis. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill. 2010;15:19600. https://doi.org/10.2807/ese.15.25.19600-en
Varella IS, Canti IC, Santos BR, Coppini AZ, Argondizzo LC, Tonin C, Wagner MB. Prevalence of acute toxoplasmosis infection among 41,112 pregnant women and the mother-to-child transmission rate in a public hospital in South Brazil. Mem Inst Oswaldo Cruz. 2009;104:383-8. https://doi.org/10.1590/S0074-02762009000200037
Prusa AR, Kasper DC, Pollak A, Gleiss A, Waldhoer T, Hayde M. The Austrian Toxoplasmosis Register, 1992-2008. Clin Infect Dis. 2015;60:e4-10. https://doi.org/10.1093/cid/ciu724
Stagni L, Romano MA, Romano A, Magli A, Briganti F, Del Pezzo MA, Buffolano W. Prenatal screening for congenital toxoplasmosis in Campania: preliminary report on activities and results. Mem Inst Oswaldo Cruz. 2009;104:374-7. https://doi.org/10.1590/S0074-02762009000200035
Gilbert R, Tan HK, Cliffe S, Guy E, Stanford M. Symptomatic toxoplasma infection due to congenital and postnatally acquired infection. Arch Dis Child. 2006;91:495-8. https://doi.org/10.1136/adc.2005.088385
Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, Rechnitzer C, Larsen SO, Nørgaard-Pedersen B, Petersen E. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet. 1999;353:1834-7. https://doi.org/10.1016/S0140-6736(98)11281-3
Aspock H. Prevention of congenital toxoplasmosis in Austria. Arch Pediatr. 2003;10:16-7.
Antoniou M, Tzouvali H, Sifakis S, Galanakis E, Georgopoulou E, Liakou V, Giannakopoulou C, Koumantakis E, Tselentis Y. Incidence of toxoplasmosis in 5532 pregnant women in Crete, Greece: management of 185 cases at risk. Eur J Obstet Gynecol Reprod Biol. 2004;117:138-43. https://doi.org/10.1016/j.ejogrb.2004.03.001
Nash JQ, Chissel S, Jones J, Warburton F, Verlander NQ. Risk factors for toxoplasmosis in pregnant women in Kent, United Kingdom. Epidemiol Infect. 2005;133:475-83. https://doi.org/10.1017/S0950268804003620
Hung CC, Fan CK, Su KE, Sung FC, Chiou HY, Gil V, da Conceicao dos Reis Ferreira M, de Carvalho JM, Cruz C, Lin YK, Tseng LF, Sao KY, Chang WC, Lan HS, Chou SH. Serological screening and toxoplasmosis exposure factors among pregnant women in the Democratic Republic of São Tome and Principe. Trans R Soc Trop Med Hyg. 2007;101:134-9. https://doi.org/10.1016/j.trstmh.2006.04.012
Liu Q, Wei F, Gao S, Jiang L, Lian H, Yuan B, Yuan Z, Xia Z, Liu B, Xu X, Zhu XQ. Toxoplasma gondii infection in pregnant women in China. Trans R Soc Trop Med Hyg. 2009;103:162-6. https://doi.org/10.1016/j.trstmh.2008.07.008
Portugal. Serviço Nacional de Saúde. Direção-Geral da Saúde. Programa Nacional para a Vigilância da Gravidez de Baixo Risco [Internet]. [cited September 7, 2018]. Available from: https://www.dgs.pt/em-destaque/programa-nacional-para-a-vigilancia-da-gravidez-de-baixo-risco.aspx
Portugal. Serviço Nacional de Saúde. Direção-Geral da Saúde. Exames laboratoriais na Gravidez de Baixo Risco. [Cited September 7, 2018]. Available from: https://www.dgs.pt/directrizes-da-dgs/normas-e-circulares-normativas/norma-n-0372011-de-30092011.aspx
Lito D, Francisco T, Salva I, Tavares MI, Oliveira R, Neto MT. Análise das Serologias para Infeções do Grupo TORCH e do Rastreio para Streptococcus do Grupo B na População de Grávidas de uma Maternidade. Acta Med Port. 2013;26(5):549-54.
Lago EG, Carvalho RL, Jungblut R, Silva VB, Fiori RM. Screening for Toxoplasma gondii antibodies in 2,513 consecutive parturient women and evaluation of newborn infants at risk for congenital toxoplasmosis. Sci Med. 2009;19:27-34.
Costa FF, Gondim APS, Lima MB, Braga JU, Souza Vieira LJE, Araujo MAL. Preventive behavior for toxoplasmosis in pregnant adolescents in the state of Ceara, Brazil. BMC Public Health. 2012;12:73. https://doi.org/10.1186/1471-2458-12-73
Bichara CNC, Canto GAC, Tostes CL, Freitas JJS, Carmo EL, Póvoa MM, Silveira EC. Incidence of congenital toxoplasmosis in the City of Belém, State of Pará, Northern Brazil, determined by a neonatal screening program: preliminary results. Rev Soc Bras Med Trop. 2012;45:122-4. https://doi.org/10.1590/S0037-86822012000100024
Dubey JP, Lago EG, Gennar SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012;139:1375-424. https://doi.org/10.1017/S0031182012000765
Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med. 1974;290:1110-6. https://doi.org/10.1056/NEJM197405162902003
Naoi K, Yano A. A theoretical analysis of the relations between the risk of congenital toxoplasmosis and the annual infection rates with a convincing argument for better public intervention. Parasitol Int. 2002;51:187-94 https://doi.org/10.1016/S1383-5769(02)00009-0
Lebech M, Joynson DHM, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E. Classification system and case definitions of Toxoplasma infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis. 1996;15:799–805. https://doi.org/10.1007/BF01701522
Mcleod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis. Mem Inst Oswaldo Cruz. 2009;104:320-44. https://doi.org/10.1590/S0074-02762009000200029
Prusa AR, Hayde M, Pollak A, Herkner KR, Kasper DC. Evaluation of the liaison automated testing system for diagnosis of congenital toxo- plasmosis. Clin Vaccine Immunol. 2012;19:1859-63. https://doi.org/10.1128/CVI.00489-12
Jaisson-Hot I, Wallon M, Kurdi M, Thulliez P, Kahi S, Cozon G, Peyron F. Congenital toxoplasmosis. Transitory negative serology. Presse Med. 2001;30(20):1001-4
Prusa AR, Kasper DC, Pollak A, Olischar M, Gleiss A, Hayde M. Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program. Clin Microbiol Infect 2015;21:191.e1-8. https://doi.org/10.1016/j.cmi.2014.09.018
Campello Porto L, Duarte EC. Association between the risk of congenital toxoplasmosis and the classification of toxoplasmosis in pregnant women and prenatal treatment in brazil, 1994 – 2009. Int J Infect Dis. 2012;16:e480-6. https://doi.org/10.1016/j.ijid.2012.01.016
Hotop A, Hlobil H, Gross U. Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2012;54:1545-52. https://doi.org/10.1093/cid/cis234
Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Kopp CB, Binquet C. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. 2013;56:1223-31. https://doi.org/10.1093/cid/cit032
Rodrigues IMX, Costa TL, Avelar JB, Amaral WN, Castro AM, Avelino MM. Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy. BMC Infect Dis. 2014;14:349. https://doi.org/10.1186/1471-2334-14-349
Sáfadi MAP, Berezin EN, Farhat CK, Carvalho ES. Clinical presentation and follow up of children with congenital toxoplasmosis in Brazil. Braz J Infect Dis. 2003;7:325-33. https://doi.org/10.1590/S1413-86702003000500007
Carvalheiro CG, Mussi-Pinhata MM, Yamamoto AY, Souza CBS, Maciel LMZ. Incidence of congenital toxoplasmosis estimated by neonatal screening: relevance of diagnostic confirmation in asymptomatic newborn infants. Epidemiol Infect. 2005;133:485-549. https://doi.org/10.1017/S095026880400353X
Lago EG, Neto EC, Melamed J, Rucks AP, Presotto C, Coelho JC, Parise C, Vargas PR, Goldbeck AS, Fiori RM. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery. Paediatr Perinat Epidemiol. 2007;21:525-31. https://doi.org/10.1111/j.1365-3016.2007.00869.x
Melamed J. Contributions to the history of ocular toxoplasmosis in Southern Brazil. Mem Inst Oswaldo Cruz. 2009;104:358-63. https://doi.org/10.1590/S0074-02762009000200032
Vasconcelos-Santos DV, Azevedo DOM, Campos WR, Oréfice F, Queiroz-Andrade GM, Carellos EV, Castro Romanelli RM, Januário JN, Resende LM, Martins-Filho OA, de Aguiar Vasconcelos Carneiro AC, Almeida Vitor RW, Caiaffa WT; UFMG Congenital Toxoplasmosis Brazilian Group. Congenital toxoplasmosis in southeastern Brazil: results of early ophtalmologic examination of a large cohort of neonates. Ophthalmology. 2009;116:2199-205. https://doi.org/10.1016/j.ophtha.2009.04.042
Vilares A, Gargaté MJ, Ferreira I, Martins S, Gomes JP. Molecular and virulence characterization of Toxoplasma gondii strains isolated from humans in Portugal. Parasitol Res. 2017;116(3):979-85. https://doi.org/10.1007/s00436-017-5374-5
Thiebaut R, Leproust S, Chene G, Gilbert R, [The Systematic Review on Congenital Toxoplasmosis Study Group]. Effectiveness of treatment for congenital toxoplasmosis: a meta-analysis of individual patients data. Lancet. 2007;369:115-22. https://doi.org/10.1016/S0140-6736(07)60072-5
Chêne G, Thiébaut R. Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis. Mem Inst Oswaldo Cruz. 2009;104(2):299-304. https://doi.org/10.1590/S0074-02762009000200025
Di Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D'Amico R, Magrini N. Prenatal education for congenital toxoplasmosis (Review). Cochrane Database of Systematic Reviews 2015, Issue 10. Art. No.: CD006171. https://doi.org/10.1002/14651858.CD006171.pub4
Paquet C, Yudin MH, Allen VM, Bouchard C, Boucher M, Caddy S, Castillo E, Money DM, Murphy KE, Ogilvie G, van Schalkwyk S. Toxoplasmosis in pregnancy, prevention, screening, and treatment. J Obstet Gynaecol Can 2013; 35(1 e Suppl A):S1-S7.
Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz MC, BonithonKopp C, Binquet C. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. 2013;56(9):1223-31. https://doi.org/10.1093/cid/cit032
Hotop A, Hlobil H, Gross U. Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2012;54(11):1545-52. https://doi.org/10.1093/cid/cis234
van de Schoondermark Ven E, Camps W, Eskes T, Meuwissen J, Galama J. Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeys. Antimicrob Agents Chemother. 1994;38:1930-6. https://doi.org/10.1128/AAC.38.9.1930
van de Schoondermark Ven E, Melchers W, Galama J, Camps W, Eskes T, Meuwissen J. Congenital toxoplasmosis: an experimental study in rhesus monkeys for transmission and prenatal diagnosis. Exp Parasitol. 1993;77:200-11. https://doi.org/10.1006/expr.1993.1077
Rodrigues LMX, Castro AM, Gomes MBF, Amaral WN, Avelino MM. Congenital toxoplasmosis: evaluation of serological methods for detection of anti Toxoplasma gondii IgM and IgA antibodies. Mem Inst Oswaldo Cruz. 2009;104:434-40. https://doi.org/10.1590/S0074-02762009000300006
Gilbert R, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, Buffolano W, Stanford MR, Petersen E; European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Ocular Sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2(8):e277. https://doi.org/10.1371/journal.pntd.0000277
Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr Infect Dis J. 2008;27:27-32. https://doi.org/10.1097/INF.0b013e318134286d
Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, Rechnitzer C, Larsen SO, Nørgaard-Pedersen B, Petersen E. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet. 1999;353:1834-7. https://doi.org/10.1016/S0140-6736(98)11281-3
Lago EG, Oliveira AP, Bender AL. Presence and duration of anti-Toxoplasma gondii immunoglobulin M in infants with congenital toxoplasmosis. J Pediatr (Rio J). 2014;90(4):363-9. https://doi.org/10.1016/j.jped.2013.12.00
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Scientia Medica
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The submission of originals to Scientia Medica implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Scientia Medica as the site of original publication.
Creative Commons License
Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.
